Flu vaccines are crucial tools in protecting public health by reducing the risk of influenza illness and its complications.

The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

Each year, as Americans roll up their sleeves for their annual flu shot, they might be surprised to learn their protection ...

When flu cases spread fast in other countries, it’s usually a predictor of what’s in store in the United States. That could ...

The mRNA platform offers the advantage of faster vaccine production, which could allow more time to decide on which flu strains to cover.

For people younger than 65, U.S.-licensed flu vaccines had an estimated effectiveness of 44% to 54% that season. Among those who completed a 6-month follow-up, the mRNA vaccine had a relative efficacy ...

The United States may be headed for a rough flu season, with a virus that causes more severe symptoms than the one last year ...

Turkeys make up approximately 2% of the entire U.S. poultry inventory, but account for 24% of new cases in commercial and ...

A mutated strain of the flu is surging worldwide, sparking concerns about a severe flu season in the U.S. Here's what to ...

With a new flu virus variant circulating, scientists fear more sickness this winter. The vaccine may be slightly less ...

The United States is bracing for the possibility of a severe flu season, fueled by the emergence of a mutated influenza ...

BOSTON — Doctors are raising alarms about a newly mutated strain of the flu that could drive cases higher this season. The ...